Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Primary African Isolates

Novel therapeutic and preventive strategies are needed to contain the HIV-1 epidemic. Broadly neutralizing human antibodies (bNAbs) with exceptional activity against HIV-1 are currently being tested in HIV-1 prevention trials. The selection of anti-HIV-1 bNAbs for clinical development was primarily...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Virol
Autors principals: Lorenzi, Julio C. C., Mendoza, Pilar, Cohen, Yehuda Z., Nogueira, Lilian, Lavine, Christy, Sapiente, Joseph, Wiatr, Marie, Mugo, Nelly R., Mujugira, Andrew, Delany, Sinead, Lingappa, Jairam, Celum, Connie, Seaman, Michael S., Caskey, Marina, Nussenzweig, Michel C.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2021
Matèries:
Pathogenesis and Immunity
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8092834/
https://ncbi.nlm.nih.gov/pubmed/33298542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01909-20
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars